Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited has announced a series of significant corporate actions, including a proposed merger and a reverse takeover, which involve the issuance of consideration shares and a new listing application. The company is also seeking a whitewash waiver and plans to increase its authorized share capital and adopt a one-off share option plan. The dispatch of the circular related to these transactions has been delayed, with the company working closely with regulators to address comments and finalize the information. The proposed merger and associated actions are subject to various conditions and approvals, and shareholders are advised to exercise caution.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative biologics, with a market focus on oncology and autoimmune diseases.
Average Trading Volume: 1,611,925
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.82B
For a thorough assessment of 6998 stock, go to TipRanks’ Stock Analysis page.